Dr. Barbara Bailus, Keck Graduate Institute (KGI) Assistant Professor of Genetics, recently received a distinguished New Investigator Grant of $500,000 over a two year period from FAST. This grant will support a research project titled, “Targeting Angelman Syndrome Therapeutics to the Brain Utilizing Novel Cell-Penetrating Peptides.”
The origins of this project can be traced back to her 2013 research which Dr. Bailus conducted as a PhD student in the lab of Dr. David Segal at UC Davis. In the lab, they designed an artificial transcription factor—a precision-tailored molecule designed to bind DNA and regulate transcription in a preprogrammed manner—to successfully treat Angelman syndrome (AS) in a mouse model.
Over the course of the two-year grant, Dr. Bailus plans to test up to three novel cell-penetrating peptides to carry the therapeutic targets into human cells and into the brain of Angelman syndrome mice.
Click here to read more about Dr. Bailus' grant from FAST >>
|